These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11248468)

  • 1. Validation in pharmaceutical analysis. Part I: an integrated approach.
    Ermer J
    J Pharm Biomed Anal; 2001 Mar; 24(5-6):755-67. PubMed ID: 11248468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation in pharmaceutical analysis. Part II: Central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data.
    Ermer J; Ploss HJ
    J Pharm Biomed Anal; 2005 Apr; 37(5):859-70. PubMed ID: 15862659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of Standard Practices for New Method Validation in Forensic Toxicology.
    Wille SMR; Coucke W; De Baere T; Peters FT
    Curr Pharm Des; 2017; 23(36):5442-5454. PubMed ID: 28714407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifecycle management in pharmaceutical analysis: How to establish an efficient and relevant continued performance monitoring program.
    Ermer J; Aguiar D; Boden A; Ding B; Obeng D; Rose M; Vokrot J
    J Pharm Biomed Anal; 2020 Mar; 181():113051. PubMed ID: 31962246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical procedure validation and the quality by design paradigm.
    Rozet E; Lebrun P; Michiels JF; Sondag P; Scherder T; Boulanger B
    J Biopharm Stat; 2015; 25(2):260-8. PubMed ID: 25357001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality by design compliant analytical method validation.
    Rozet E; Ziemons E; Marini RD; Boulanger B; Hubert P
    Anal Chem; 2012 Jan; 84(1):106-12. PubMed ID: 22107128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General method validation guidelines for pharmaceutical samples.
    Inman EL; Frischmann JK; Jimenez PJ; Winkel GD; Persinger ML; Rutherford BS
    J Chromatogr Sci; 1987 Jun; 25(6):252-6. PubMed ID: 3611281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting acceptance criteria for validation of analytical methods of drug eluting stents: Minimum requirements for analytical variability.
    Kamberi M; Garcia H; Feder DP; Rapoza RJ
    Eur J Pharm Sci; 2011 Feb; 42(3):230-7. PubMed ID: 21126583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of stability study designs.
    Lin TY; Chen CW
    J Biopharm Stat; 2003 Aug; 13(3):337-54. PubMed ID: 12921386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I.
    Hubert P; Nguyen-Huu JJ; Boulanger B; Chapuzet E; Chiap P; Cohen N; Compagnon PA; Dewé W; Feinberg M; Lallier M; Laurentie M; Mercier N; Muzard G; Nivet C; Valat L
    J Pharm Biomed Anal; 2004 Nov; 36(3):579-86. PubMed ID: 15522533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and quality assurance of planar chromatographic procedures in pharmaceutical analysis.
    Ferenczi-Fodor K; Végh Z; Nagy-Turák A; Renger B; Zeller M
    J AOAC Int; 2001; 84(4):1265-76. PubMed ID: 11501931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life cycle management of analytical methods.
    Parr MK; Schmidt AH
    J Pharm Biomed Anal; 2018 Jan; 147():506-517. PubMed ID: 28666555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and economic HPLC performance qualification.
    Kaminski L; Degenhardt M; Ermer J; Feussner C; Höwer-Fritzen H; Link P; Renger B; Tegtmeier M; Wätzig H
    J Pharm Biomed Anal; 2010 Feb; 51(3):557-64. PubMed ID: 19801176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method validation across the disciplines--critical investigation of major validation criteria and associated experimental protocols.
    Stöckl D; D'Hondt H; Thienpont LM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2180-90. PubMed ID: 19157996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transfer of analytical procedures.
    Ermer J; Limberger M; Lis K; Wätzig H
    J Pharm Biomed Anal; 2013 Nov; 85():262-76. PubMed ID: 23978903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tests for robustness of biomedical and pharmaceutical analytic methods].
    Vander Heyden Y
    Verh K Acad Geneeskd Belg; 2003; 65(1):47-73. PubMed ID: 12802896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal part IV. Examples of application.
    Hubert P; Nguyen-Huu JJ; Boulanger B; Chapuzet E; Cohen N; Compagnon PA; Dewé W; Feinberg M; Laurentie M; Mercier N; Muzard G; Valat L; Rozet E
    J Pharm Biomed Anal; 2008 Nov; 48(3):760-71. PubMed ID: 18768284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalidation in pharmaceutical analysis. Part I. Fundamentals and critical discussion.
    Grdinić V; Vuković J
    J Pharm Biomed Anal; 2004 May; 35(3):489-512. PubMed ID: 15137975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical considerations in setting product specifications.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2015; 25(2):280-94. PubMed ID: 25358110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical instrument qualification in capillary electrophoresis.
    Cianciulli C; Wätzig H
    Electrophoresis; 2012 Jun; 33(11):1499-508. PubMed ID: 22736350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.